FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.

Lv, Zheng; Cui, Bo; Huang, Xing; Feng, Hua-Yi; Wang, Tao; Wang, Han-Feng; Xuan, Yun-Dong; Li, Hong-Zhao; Ma, Xin; Huang, Yan; Zhang, Xu.

Afiliação

Lv Z; School of Medicine, Nankai University, Tianjin, China.
Cui B; Medical School of Chinese PLA, Beijing, China.
Huang X; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Feng HY; Medical School of Chinese PLA, Beijing, China.
Wang T; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Wang HF; Medical School of Chinese PLA, Beijing, China.
Xuan YD; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Li HZ; Medical School of Chinese PLA, Beijing, China.
Ma X; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Huang Y; Medical School of Chinese PLA, Beijing, China.
Zhang X; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.